reference/3258490

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3258490

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	70
issn	0920-1211
pageRange	64-70
publicationName	Epilepsy Research
startingPage	64
bibliographicCitation	Gidal BE, Mintzer S, Schwab M, Schutz R, Kharidia J, Blum D, Grinnell T, Sunkaraneni S. Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters. Epilepsy Res. 2017 Sep;135():64–70. doi: 10.1016/j.eplepsyres.2017.05.005. PMID: 28624574.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ce4ff55fcc11e539dc33465564bcaba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cf97f8bdb97b85065131cd066562215 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7c22cd367fd0df9af91737e0ddc1e57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_730bbbbc200b599f5e3e77103b16c81c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a65dd83da83c13eaf7598cafcddf244f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c98645bf4d4642c48521bf963d58bc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4899f0689b495574a1c794590e160526 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66933bddb2d61f3fac2cab295a7a394a
date	201709
identifier	https://doi.org/10.1016/j.eplepsyres.2017.05.005 https://pubmed.ncbi.nlm.nih.gov/28624574
isPartOf	https://portal.issn.org/resource/ISSN/0920-1211 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters
discusses	http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0572254 http://id.nlm.nih.gov/mesh/M0402344 http://id.nlm.nih.gov/mesh/M0028567 http://id.nlm.nih.gov/mesh/M0379230 http://id.nlm.nih.gov/mesh/M0006249
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000068718Q000493 http://id.nlm.nih.gov/mesh/D003984Q000493 http://id.nlm.nih.gov/mesh/D019161Q000493 http://id.nlm.nih.gov/mesh/D000927Q000493
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D004347 http://id.nlm.nih.gov/mesh/D019540 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000068718Q000008 http://id.nlm.nih.gov/mesh/D001682 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D000068718Q000097 http://id.nlm.nih.gov/mesh/D000068718Q000009 http://id.nlm.nih.gov/mesh/D016018 http://id.nlm.nih.gov/mesh/D003984Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D019161Q000097 http://id.nlm.nih.gov/mesh/D000927Q000009 http://id.nlm.nih.gov/mesh/D026901Q000378 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D019161Q000009 http://id.nlm.nih.gov/mesh/D019161Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45114162 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282455 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87071853 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9881504 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_67aadc7c7b2194fc04decca410c17b42 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446157 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9869776 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12086784 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID179344

Total number of triples: 67.